Lu S L, Zhang W C, Akiyama Y, Nomizu T, Yuasa Y
Department of Hygiene and Oncology, Tokyo Medical and Dental University School of Medicine, Japan.
Cancer Res. 1996 Oct 15;56(20):4595-8.
To characterize the tumorigenetic role of the transforming growth factor beta type II receptor (RII) gene, we defined its genomic structure, which consists of seven exons. The sequences of exon-intron junctions were determined to facilitate mutation analysis of each exon. Twenty-five carcinomas and five adenomas from hereditary nonpolyposis colorectal cancer patients were analyzed for mutations in the entire coding region. Four missense mutations (two in adenomas and two in carcinomas) were found in the 10 cases carrying the polyadenine deletions in one allele. These results indicate that RII shares the two-hit inactivation mechanism with tumor suppressor genes and that mutations of it may occur in the early stage of tumorigenesis.
为了阐明转化生长因子βⅡ型受体(RII)基因在肿瘤发生中的作用,我们确定了其基因组结构,该结构由七个外显子组成。确定了外显子-内含子连接序列,以利于对每个外显子进行突变分析。对来自遗传性非息肉病性结直肠癌患者的25例癌和5例腺瘤进行了整个编码区的突变分析。在一个等位基因中携带多聚腺嘌呤缺失的10例病例中发现了4个错义突变(2个在腺瘤中,2个在癌中)。这些结果表明,RII与肿瘤抑制基因具有双打击失活机制,并且其突变可能发生在肿瘤发生的早期阶段。